High probability bearish signal on Cronos Group (CRON)
Cronos Group (Nasdaq: CRON) is a rather unique company. It is considered a healthcare company as far as its sector designation, but it considers itself to be an investment firm that invests in medical marijuana companies. Cannabis investing has been a prominent storyline over the last few years and that has helped the stock move up sharply in the last two years.
Despite the rally, the stock has been trending lower in the last four and a half months. A trend channel has formed that defines the cycles within the overall trend. This channel is different in the way that I drew it because it was the lower rail that stood out to me first. I connected the lows from February, March, April, and May to form the lower rail. I then drew a parallel line and used the high from March as the starting point. What we see on the chart below is that the stock just hit the upper rail of the channel and then turned lower.
We see that the stock was overbought based on the daily stochastic readings, but the indicators turned lower and made a bearish crossover on June 13.
The Tickeron Trend Prediction Engine generated a bearish signal on the same day as the stochastics crossover. The signal showed a confidence level of 89% and past predictions on the stock have been successful 88% of the time. The signal calls for a drop of at least 4% over the next month.
Momentum Indicator for CRON turns negative, indicating new downward trend
CRON saw its Momentum Indicator move below the 0 level on May 15, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 109 similar instances where the indicator turned negative. In of the 109 cases, the stock moved further down in the following days. The odds of a decline are at .
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for CRON moved out of overbought territory on April 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 19 similar instances where the indicator moved out of overbought territory. In of the 19 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRON declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
CRON broke above its upper Bollinger Band on April 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 82 cases where CRON's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for CRON just turned positive on May 12, 2026. Looking at past instances where CRON's MACD turned positive, the stock continued to rise in of 57 cases over the following month. The odds of a continued upward trend are .
CRON moved above its 50-day moving average on May 11, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CRON crossed bullishly above the 50-day moving average on April 17, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CRON advanced for three days, in of 222 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 117 cases where CRON Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CRON’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.915) is normal, around the industry mean (65.146). P/E Ratio (23.909) is within average values for comparable stocks, (60.387). CRON's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.987). CRON has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (6.305) is also within normal values, averaging (109.344).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRON’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
pharmaceutical, medical marijuana, cannabis
Industry PharmaceuticalsGeneric
Advertisement